Pancreatic Cancer: Pathogenesis and Diagnosis

Area of Science:

• Oncology
• Genetics

Background:

• Pancreatic cancer is a fatal malignancy with an aggressive course, predominantly affecting men aged 40-85.
• Its incidence is increasing, accounting for 2% of all cancers and 5% of cancer deaths.
• It is the leading asymptomatic cancer, with 90% of cases being adenocarcinomas and 10% having a familial predisposition.

Purpose of the Study:

• To highlight the challenges in early detection of pancreatic cancer.
• To discuss the role of genetic mutations in pancreatic cancer development and metastasis.

Main Methods:

• Literature review on pancreatic cancer epidemiology and genetics.
• Analysis of current understanding of disease progression and detection difficulties.

Main Results:

• Pancreatic cancer presents with no early signs, leading to late diagnosis and rapid spread.
• Hereditary germline or somatic acquired mutations in cancer-related genes are implicated in its development, progression, and metastasis.

Conclusions:

• Pancreatic cancer remains one of the deadliest cancers due to its aggressive nature and late detection.
• Understanding the genetic underpinnings is crucial for potentially improving diagnosis and treatment strategies.